What We Do
Shenkan Advisors assists healthcare company boards, management teams, and investors with strategic decisions and due diligence on acquisitions and investments using our proprietary market research. We advise institutional investors and companies on investment decisions, market assessments, and company valuations. As a fundamental part of our assessments we survey and interview several thousand physicians, medical providers, medical facility administrators, and payors annually. This qualitative and quantitative primary research is incorporated into our financial models and rigorous financial analysis. We deliver results and include our clients in our research process to build their conviction to act on our recommendations.
We help private equity investors and companies screen mergers and acquisitions, perform due diligence on acquisitions or investments, and evaluate white spaces. Our involvement with deals continues after the acquisition as we develop the business strategy. This includes how to create long-term value for the company and a roadmap for future bolt-on acquisitions. As the company executes the acquisition strategy we stay involved and provide future due diligence on complementary acquisitions. Our exit analysis includes valuation and determining when and how to best exit a business or investment. Our analysis can help to gain agreement by the full Board or management team.
Boards and management teams also call on us to analyze capital allocation including whether to: fund a clinical trial, invest in market development, pursue reimbursement for a procedure, enter new markets, or to partner or independently market a product. We also assist companies to develop strategic marketing assessments for existing and new markets. These assessments include market size, penetration, share, growth, segmentation, and pricing. Our high quality work has enabled Shenkan Advisors to become a trusted, value-added, and long-term partner and advisor to our clients.
